The US Food and Drug Administration (FDA) has approved osimertinib (Tagrisso, AstraZeneca Pharmaceuticals) for the treatment ...
Tagrisso, which targets exon 19 deletions or exon 21 (L858R) mutations, received the approval following a priority review.
The Zacks Daily presents the best research output of our analyst team. Today's Daily features new research reports on 16 ...
In several short films directed by Reed Morano, the “What science can do” campaign features stories from a cancer patient and an asthma patient.
Boris Johnson considered invading the Netherlands to seize Covid vaccines during the height of the pandemic, he has revealed ...
AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune ...
Boris Johnson says he considered a proposal to send UK special forces into the Netherlands to grab Covid vaccines during a ...
AstraZeneca and Daiichi Sankyo's Dato-DXd failed to improve survival in a breast cancer study. Gilead Sciences' Kite will bow ...
AstraZeneca’s FluMist approval for self-administration could increase flu vaccine uptake: GlobalData
According to GlobalData, the US vaccination rate for seasonal influenza during the 2023-2024 season was estimated to be 47%, ...
The current economic landscape presents a mix of signals as market participants assess the necessity of additional interest ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Toyota Motor Corp. (TM), AstraZeneca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback